Authors

Anne Chiang, MD, PhD, Yale School of Medicine Smilow Cancer Hospital

Latest:

Redefining SCLC: Molecular Subtypes and Blood Biomarkers Guide Therapy

Key opinion leaders investigate the potential impact of redefining small cell lung cancer (SCLC) as a molecularly heterogeneous malignancy on personalized treatment strategies for SCLC subtypes with distinct therapeutic vulnerabilities, while exploring the emerging role of blood-based biomarkers in shaping the evolving treatment landscape for SCLC.

Anne Covey, MD

Latest:

Dr. Covey on Recent and Future Changes to the NCCN Guidelines for HCC

Anne Covey, MD, interventional radiologist, Memorial Sloan Kettering Cancer Center, discusses recent and future changes to locoregional treatment approaches for hepatocellular carcinoma (HCC).

Anne Favret, MD

Latest:

Dr. Favret on Extending Survival and Improving Outcomes in Breast Cancer

Anne Favret, MD, discusses the importance of clinical trials in the breast cancer space.

Anne Hubbard

Latest:

Why Radiation Oncology Needs an APM

Alternative payment models (APMs) are the future of Medicare payment.

Anne Julia Klompenhouwer, MD

Latest:

Dr. Klompenhouwer on the Resection of Larger Hepatocellular Adenomas

Anne Julia Klompenhouwer, MD, Department of Surgery at Erasmus Medical Center in Rotterdam, The Netherlands, discusses when it is justified to resect a larger hepatocellular adenoma for patients with hepatocellular carcinoma (HCC).

Anne Katz, RN, PhD

Latest:

Anne Katz Discusses Cancer and Sexuality

Anne Katz, from the University of Manitoba, Discusses Cancer and Sexuality

Anne Kirchhoff, PhD, MPH

Latest:

Supporting Adolescents and Young Adults With Cancer From Diagnosis Through Survivorship

Due to the unique characteristics of adolescents and young adults, there is a growing effort to address their oncology needs.

Anne Marie McCarthy, MD

Latest:

Dr. Anne Marie McCarthy on Measuring Breast Density with Computer Algorithms

Anne Marie McCarthy, MD, research fellow, Massachusetts General Hospital, discusses using computer algorithms to measure breast density.

Anne McTiernan, MD, PhD

Latest:

Dr. McTiernan on Biomarkers in Breast Cancer

Anne McTiernan, MD, PhD, research professor of epidemiology, University of Washington, member, Fred Hutchinson Cancer Research Center, discusses the biomarkers that are associated with poor prognosis in patients with breast cancer.

Anne S. Tsao, MD

Anne S. Tsao, MD, MD Ande

Anne S. Tsao, MD, MD Anderson

Anne S. Tsao, MD, MD Anderson Cancer Center

Anobel Odisho, MD

Latest:

Dr. Odisho on the Impact of a Risk Prediction Model on Treatment Approaches in RCC

Anobel Odisho, MD, urologic oncology fellow, University of Washington, discusses the impact of a risk prediction model on treatment approaches in renal cell carcinoma.

Anthony Accurso, MD

Latest:

The Personal Touch: Patients Are More Than Their Charts

Anthony Accurso, MD, offers a patient more time managing their cancer and a better quality of life.

Anthony B. El-Khoueiry, MD

Latest:

Dr El-Khoueiry on Regorafenib/Pembrolizumab in Advanced HCC After Prior Anti–PD-1/L1 Therapy

Anthony B. El-Khoueiry, MD, on data for regorafenib plus pembrolizumab in pretreated advanced hepatocellular carcinoma.

Anthony B. El-Khoueiry, MD, Southern California Clinical

Anthony Berberabe, MPH

Latest:

Testing Reveals Extent of Lynch Syndrome

The presence of Lynch syndrome correlates with microsatellite-instability status and DNA mismatch-repair deficiency across a variety of tumor types.

Anthony Conley MD

Latest:

Phase II Clinical Trial of Intratumoral Dendritic Cells Injections and Neoadjuvant Radiotherapy in Resectable Soft Tissue Sarcomas

Neoadjuvant radiation with dendritic cell injections has the potential to be safe, effective, and immunogenic in high-grade soft tissue sarcoma and needs to be confirmed in randomized larger clinical trials.

Anthony Costales, MD

Latest:

Dr. Costales on Study of Adjuvant Therapy in Uterine Leiomyosarcoma

Anthony Costales, MD, gynecologic oncology fellow, Cleveland Clinic, discusses a study of adjuvant therapy for patients with uterine leiomyosarcoma.